Sort
82,697 grants matching “vaccine development”
Development of a Next Generation Vaccine for Smoking Cessation and Relapse Preven
$2,996,608Lloyd Patrick Johnston · Selecta Biosciences, Inc. · RC3 · FY2010 · DA
Increasing Availability of Emulsion Adjuvants via Synthetic Biology
$2,996,311Chase Kempinski · Enepret, Inc. · N44 · FY2022 · AI
Structure-function analysis of infection- and vaccine-induced B-cell repertoires
$2,994,848Stephen C Harrison · Boston Children'S Hospital · P01 · FY2023 · AI
Structure-function studies of alpha-and flaviviruses
$2,994,435Purdue University West Lafayette · P01 · FY2004 · AI
Basic Research Support for the CCR
$2,994,352Thomas A Misteli · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA
INSTITUTE FOR CLINICAL AND TRANSLATIONAL RESEARCH
$2,993,259Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2011 · RR
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections-A5407 Third Supplement
$2,991,790Judith S. Currier · University Of California Los Angeles · UM1 · FY2025 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax
$2,991,269Kenneth Mark Coggeshall · Oklahoma Medical Research Foundation · U19 · FY2010 · AI
Moffitt Cancer Center Support Grant
$2,990,966John L. Cleveland · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2020 · CA
Moffitt Cancer Center Support Grant
$2,990,966John L. Cleveland · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2021 · CA
Moffitt Cancer Center Support Grant
$2,990,966Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2018 · CA
Moffitt Cancer Center Support Grant
$2,990,966Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2017 · CA
Sample Collection and General Screening Protocols
$2,990,944Lesia K Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
LEADERSHIP GROUP FOR ADOLESCENT MEDICINE TRIALS NETWORK
$2,988,964University Of Alabama At Birmingham · U01 · FY2002 · HD
Hematopoietic Cell Transplantation for Hematologic Malignancies
$2,987,761Stephen J Forma · Beckman Research Institute/City Of Hope · P01 · FY2009 · CA
GH19-005, Advancing Public Health Research in Bangladesh
$2,987,356Sayera Banu · International Ctr/Diarrhoeal Dis Res · U01 · FY2020 · GH
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax
$2,986,968Kenneth Mark Coggeshall · Oklahoma Medical Research Foundation · U19 · FY2009 · AI
Clinical Studies of Vaccines for Pandemic Influenza
$2,983,617Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Phase II Clinical Trial to Evaluate a Vaccine Candidate for Gonococcal Infection
$2,981,138National Institute Of Allergy And Infectious Diseases · Y01 · FY2022 · AI
Vaccine Induced Immunity in the Young and Aged
$2,976,722Rafi Ahmed · Emory University · U19 · FY2013 · AI
Project 3- Mucosal Determinants of Virus Transmission
$2,974,489Guido Silvestri · University Of Maryland Baltimore · P01 · FY2017 · AI
NIAID Centers of Excellence for Influenza Research and Response (CEIRR): Universal Influenza Vaccine Research Activities
$2,973,488Anice Lowen · Emory University · N01 · FY2025 · AI
Operations and Management support component
$2,972,587Barton F Haynes · Duke University · UM1 · FY2018 · AI
Phase II - Advanced Development of a Vaccine for Salmonella Paratyphi A
$2,972,412Yawei Ni · Kj Biosciences, Llc · N44 · FY2019 · AI
Specific and Broadly Active Monoclonal Antibody Therapeutics Against The Filoviruses
$2,972,368Erica Ollmann Saphire · La Jolla Institute For Immunology · U19 · FY2019 · AI